如何评估顺势疗法预后因素研究的变化?
Lex Rutten1, José E Eizayaga2, Harleen Kaur3
1Independent researcher, Breda, The Netherlands.
概括
在预后因素研究 (PFR) 中对极性症状 (PS) 的统计分析揭示了不对称性. 累积二项概率 (CBP) 有助于对PFR结果的可靠性进行分类,有助于临床决策.
科学领域:
- 顺势疗法研究 研究 顺势疗法研究
- 医学中的统计分析.
- 预测因素研究 (PFR) 是指预测因素的研究.
背景情况:
- 预后因素研究 (PFR) 通常涉及分析极性症状 (PS),这些症状具有相反的值 (例如,改善/欲望与恶化/厌恶).
- 在PS频率分布中观察到的差异,例如"欲望盐"与"厌恶盐"对于*Arsenicum专辑*,引发了关于统计变化的问题.
- 之前的研究和当前的数据收集方法可能导致PS中不对称的频率分布.
研究的目的:
- 将预后因素研究 (PFR) 结果的可靠性分类,特别是对极地症状 (PS).
- 评估统计变异对观察到的PS差异的影响.
- 为了比较累积二项概率 (CBP) 和95%信心区间 (95%CI) 在PFR日常实践中的有用性.
主要方法:
- 对极性症状 (PS) 频率分布的分析和与以前的研究进行比较.
- 计算累积二项概率 (CBP) 和95%信心区间 (95%CI) 以评估统计变化.
- 使用95%CI对CBP进行校准,并通过可比症状对结果进行验证.
主要成果:
- 在几个PS中观察到不对称性,与之前的研究不同,可能是由于使用问卷和不考虑临床专业知识.
- 这种不对称性可能导致"上限效应"和降低概率比率 (LRs).
- CBP与95%的CI相关,为PFR结果提供了一定的统计确定性,这些结果可以被分类为"确定"",可能"",可能"或"可疑".
结论:
- 在PS频率分布中的不对称性可能来自于从业人员在症状评估过程中不充分利用专家知识.
- 基于CBP的可靠性分类更具信息性,并且更好地被顺势疗法专家理解,尽管它仍然部分主观.
- 对结果的验证和临床判断对于确定PFR发现的临床有效性至关重要;建议研究人员和从业人员接受统计学和顺势疗法的培训.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
184
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
184
Comparing the Survival Analysis of Two or More Groups
303
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
303
Factors Affecting Drug Response: Overview
2.4K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.4K
Regression Toward the Mean
6.5K
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.5K
Factors Affecting Illness
4.5K
When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness,...
For instance, risk factors are connected to illness,...
4.5K
Analysis of Population Pharmacokinetic Data
397
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
397


